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White spot syndrome virus (WSSV) is one of the most virulent pathogens causing high mortality in
shrimp. Herein, the characterization of VP24, a major structural protein of WSSV, is described.
When purified virions were subjected to Nonidet P-40 treatment to separate the envelopes
from the nucleocapsids, VP24 was found to be present exclusively in the envelope fraction. Triton
X-114 extraction also indicated that VP24 behaves as an envelope protein. Immunoelectron
microscopy further confirmed that VP24 is located in the virion envelope. Far-Western experiments
showed that VP24 interacts with VP28, another major envelope protein of the WSSV virion.
To investigate the function of VP24, WSSV was neutralized with various amounts of anti-VP24
IgG and injected into crayfish. The results showed that anti-VP24 IgG could partially attenuate
infection with WSSV. It is concluded that VP24 is an envelope protein and functions at an early
stage in virus infection.
INTRODUCTION
White spot syndrome virus (WSSV) represents a novel genus
of DNA viruses, Whispovirus, belonging to the family Nima-
viridae (Mayo, 2002). It is a major pathogen in shrimp
aquaculture and can also infect most species of crustacean
(Chou et al., 1995; Lo et al., 1996; Chang et al., 1998; Wang
et al., 1998; Chen et al., 2000; Corbel et al., 2001; Sahul
Hameed et al., 2001). First appearing in the 1990s in Taiwan,
WSSV spread quickly to South-East Asia, the Indian sub-
continent and Central and Latin America, causing catastro-
phic economic losses. Electron-microscopy studies reveal
that WSSV is an enveloped, non-occluded and bacilliform
virus (Wang et al., 1995; Wongteerasupaya et al., 1995). The
virus contains a double-stranded, circular DNA of about
300 kb, which has been sequenced completely in three
WSSV isolates (van Hulten et al., 2001a; Yang et al., 2001;
Chen et al., 2002). Approximately 180 open reading frames
(ORFs) are revealed by the analysis of the WSSV genomic
DNA sequence (GenBank accession no. AF332093).
In previous studies, major structural proteins of WSSV
virions were separated by gel electrophoresis and analysed
by mass spectrometry, and more than 30 polypeptides
matching WSSV ORFs were identified with a molecular
mass range of 7–660 kDa (Huang et al., 2002a; Tsai et al.,
2004; Zhang et al., 2004). At present, more attention has
been paid to the viral envelope proteins, as these commonly
play key roles in the primary-infection phase. So far, about
10 genes of WSSV have been identified to encode envelope
proteins by using Western blotting or immunoelectron
microscopy (van Hulten et al., 2000b, 2002; Huang et al.,
2002b; Zhang et al., 2002a, b, 2004; Li et al., 2005, 2006; Zhu
et al., 2005, 2006). Some of these envelope proteins, such as
VP28, VP68, VP281 and VP31, were believed to be involved
in WSSV infection by in vivo neutralization experiments
(van Hulten et al., 2001b; Li et al., 2005; Wu et al., 2005) and
VP26 was supposed to help the viral nucleocapsid to move
toward the nucleus by interacting with actin or cellular
actin-binding proteins (Xie & Yang, 2005). However, due to
the lack of an established shrimp-cell line, little is known
about the molecular events underlying the WSSV life cycle
and mode of infection.
VP24, the product of the wsv002 gene of WSSV (Yang et al.,
2001), is a major structural protein of WSSV. Our initial
inspection of the VP24 gene sequence suggested that it
might be a component of the viral envelope. However, VP24
was thought to be a nucleocapsid protein (van Hulten et al.,
2000a). In this report, a more precise localization of VP24
within WSSV virions was determined. In addition, far-
Western and neutralization experiments were conducted
to further characterize the possible role of VP24 in WSSV
infection.
METHODS
Expression and purification of recombinant VP24 (rVP24) in
Escherichia coli. The WSSV VP24 gene (wsv002) was amplified
from the genomic DNA of WSSV with the forward primer 59-
GAGAGGATCCACCAACATAGAACTTAAC-39 and the reverse
primer 59-GAGAGAATTCTTTTTCCCCAACCTTAAAC-39, carrying
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recognition sequences for the BamHI and EcoRI restriction enzymes
(underlined). The amplified DNA fragment contained sequences
corresponding to VP24 aa 26–208. The PCR product was digested
with BamHI and EcoRI and cloned into pET-His (Shenzhen Gene
Power). The recombinant plasmid was transformed into E. coli BL21
(DE3) and cultures were induced with 0?1 mM IPTG for 6 h at
30 uC and harvested. The bacterial pellets were resuspended and
sonicated and the supernatant recovered after centrifugation was
loaded onto a column of Ni2NTA resin (Qiagen). The recombinant
protein was purified under native conditions according to the
instructions of the QIAexpressionist system (Qiagen).
Preparation of antibody. The purified proteins were used as anti-
gen to immunize mice by intradermal injection once every 10 days.
Antigen (20 mg) was mixed with an equal volume of Freund’s com-
plete adjuvant (Sigma) for the first injection. Subsequent injections
were conducted by using 20 mg antigen mixed with an equal volume
of Freund’s incomplete adjuvant (Sigma). Four days after the last
injection, mice were exsanguinated and antisera were collected. The
immunoglobulin (IgG) fractions were purified by protein A–
Sepharose (Amersham Biosciences) and stored at 270 uC.
Virus purification and detergent extraction of intact virus.
WSSV inoculum was prepared from Penaeus japonicus shrimp with
pathologically confirmed infection. The infection of healthy crayfish,
Procambarus clarkii, and the purification of virus were performed as
described previously (Xie et al., 2005). Briefly, the tissues of infected
crayfish, excluding the hepatopancreas, were homogenized in TNE
buffer (50 mM Tris/HCl, 400 mM NaCl, 5 mM EDTA, pH 8?5) and
then centrifuged at 3500 g for 5 min at 4 uC. After filtering by nylon
net (400 mesh), the supernatant was centrifuged at 30 000 g for 30 min
at 4 uC. Then, the upper loose pellet was rinsed out carefully and the
lower white pellet was suspended in 10 ml TN buffer (20 mM Tris/
HCl, 400 mM NaCl, pH 7?4). After centrifugation at 3500 g for 5 min,
the virus particles were sedimented by centrifugation at 30 000 g for
20 min at 4 uC and then resuspended and kept in 1 ml TN buffer.
Viral envelope was separated from the nucleocapsids as described by
van Hulten et al. (2000b). Briefly, intact virions were mixed with an
equal volume of 2 % Nonidet P-40 (NP-40) and incubated for 30 min
at room temperature with gentle shaking. The extract was separated
into soluble (envelope) and insoluble pellet (nucleocapsid) fractions by
centrifugation at 30 000 g for 20 min at 4 uC.
For the Triton X-114 extraction (Bordier, 1981), intact virions were
mixed with an equal volume of 2 % Triton X-114 and incubated at 4 uC
for 30 min. The mixture was sedimented at 15 000 g for 5 min to
separate the phases. Both phases were subjected to a second round of
Triton X-114 extraction. All samples were concentrated by acetone
precipitation at 220 uC and analysed by SDS-PAGE, transferred to a
membrane and detected with anti-VP24 serum.
Immunoelectron microscopy. Purified WSSV virion and nucleo-
capsid suspensions were mounted on Formvar- or carbon-coated
nickel grids (300 mesh), respectively, and incubated for 15 min at
room temperature. Then, the grids were blocked with 2 % BSA in
PBS for 1 h, followed by incubation with anti-VP24 serum (1 : 1000
dilution in 2 % BSA) for 1 h. After washing three times with PBS,
the grids were incubated with goat anti-mouse IgG conjugated to
10 nm colloid gold (Sigma) for 1 h. Subsequently, the grids were
washed three times with PBS and briefly negatively stained with 2 %
phosphotungstic acid (PTA; pH 7?0) for 1 min. Specimens were
examined under a transmission electron microscope (JEM 100 cxP).
For control experiments, pre-immune mouse serum was used to
replace the primary antibody indicated above.
Gel electrophoresis and Western blot. Proteins dissolved in
loading buffer were separated by standard SDS-PAGE (Laemmli,
1970) with a 12 % resolution gel and a 4 % stacking gel and then
transferred onto a PVDF transfer membrane (Amersham Biosciences).
The blot was immersed in incubation buffer (20 mM Tris/HCl,
150 mM NaCl, 0?05 % Tween 20, 3 % non-fat milk, pH 7?5) at 4 uC
overnight followed by incubating with anti-VP24 serum (1 : 5000
dilution) for 2 h. Subsequently, alkaline phosphatase (AP)-conjugated
goat anti-mouse IgG (Promega) (1 : 7500 dilution) was used as the
secondary antibody and detection was performed with a substrate
solution containing 4-chloro-1-naphthol and X-phosphate (Roche).
Biotinylation of rVP24 protein and far-Western experiment.
Purified rVP24 protein was dialysed against PBS and adjusted to a
concentration of 1 mg ml21. Two hundred micrograms of EZ-Link
sulfo-NHS-LC-biotin (Pierce) was added directly to 1 ml rVP24
protein solution. The mixture was incubated at room temperature
for 30 min and dialysed against PBS to remove the unreacted biotin
reagent.
The viral structural proteins were separated by SDS-PAGE, transferred
to a PVDF membrane and renatured gradually at 4 uC overnight in
HEPES buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 1 mM
dithiothreitol, 0?1 % Tween 20, 10 % glycerol, pH 7?5) containing 5 %
non-fat milk. The blot was washed and incubated with 0?5 mg bio-
tinylated rVP24 in 5 ml incubation buffer for 1 h at room temperature.
The blot was subsequently washed three times and incubated with
AP-conjugated streptavidin (Promega) for 1 h at room temperature.
After washing three times, the detection was performed with a sub-
strate solution containing 4-chloro-1-naphthol and X-phosphate.
Biotinylated glutathione S-transferase (GST) was incubated with viral
structural proteins as a control.
Coimmunoprecipitation experiments. The viral envelope proteins
were dialysed against PBS and labelled with EZ-Link sulfo-NHS-LC-
biotin as described above. The biotinylated envelope proteins were
incubated with anti-VP24 serum (1 : 250 dilution) overnight at 4 uC.
Subsequently, 10 ml protein A–Sepharose beads was added to the
mixture and incubated for 1 h at 4 uC. The Sepharose beads were
collected by centrifugation and washed five times with 500 ml PBS.
The bound proteins were dissociated from the antibody by boiling
in loading buffer for 5 min and separated on 12 % SDS-PAGE gels.
The separated proteins were transferred onto a PVDF membrane
and the biotinylated proteins were detected as described above.
In vivo neutralization assay. Virus concentration was quantified
by competitive PCR as described by Xu et al. (2001). The in vivo
neutralization experiment was performed as described by van Hulten
et al. (2001b). Prior to injection, 100 ml virions (equivalent to
106 copies) was incubated with anti-GST IgG (group 2, 20 mg) or
with various amounts of anti-VP24 IgG (group 3, 5 mg; group 4,
10 mg; group 5, 20 mg). Then, the mixture of antibody and WSSV
was injected intramuscularly into crayfish. At the same time, a nega-
tive control (0?9 % NaCl, group 6) and a positive control (WSSV
only, group 1) were included in the injection. For each treatment,
20 crayfish were used. Crayfish mortality caused by WSSV was mon-
itored daily.
RESULTS
Expression and purification of rVP24
Computer analysis (ANTHEPROT software) of the 208 aa of
VP24 showed that it has a strong hydrophobic region typi-
cal of membrane-spanning proteins, i.e. a stretch of 10–23
hydrophobic amino acids (Fig. 1), consistent with the
hydrophilic analysis (van Hulten et al., 2000a). For the
convenience of purification of the soluble VP24, a truncated
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form of VP24 without the N-terminal transmembrane
domain from aa 1 to 25 was cloned into a bacterial expres-
sion vector upstream of a (His)6 tag. rVP24 was expressed as
a soluble protein and purified through an Ni–NTA affinity
column.
VP24 associates with viral envelopes
The location of VP24 in the virion is controversial (see
Introduction). In this study, we used some different criteria
that are used widely to categorize the physical properties of
proteins to define the localization of VP24. First, purified
WSSV virions were subjected to treatment with 1 % NP-40.
Typically, envelope-associated proteins can be released from
virions with a non-ionic detergent. As shown in Fig. 2,
following NP-40 treatment, the typical envelope proteins
(VP28 and VP19) were present exclusively in the envelope
fraction and the nucleocapsid protein (VP15) was found
completely in the nucleocapsid fraction, as expected. VP24
was only found in the envelope fraction, which was validated
by Western blot. When the virions were subjected to treat-
ment with other detergents, such as Triton X-100, VP24 also
partitioned entirely in the envelope fraction, consistent with
the literature data reported previously (Xie et al., 2005).
Subsequently, to test whether the hydrophobicity of VP24
was sufficient for envelope association, we extracted purified
WSSV virions with Triton X-114. Following phase separation,
Triton X-114 separates proteins predominantly according to
their hydrophobicity, with hydrophobic and hydrophilic
proteins tending to partition into the detergent phase and
the aqueous phase, respectively (Bordier, 1981). As envelope
proteins contain hydrophobic sequences that anchor them
in the envelope, this phase-separation technique can be used
operationally to separate envelope proteins from soluble
proteins. After this extraction technique, VP24 was found
completely in the detergent phase, indicating that it behaves
as a hydrophobic protein (Fig. 3).
In order to further confirm the envelope association of
VP24, a more precise localization of VP24 in the virions of
WSSV was determined by immunoelectron microscopy.
The results showed that the gold particles could be seen on
the viral envelopes when using anti-VP24 serum as the
primary antibody (Fig. 4a), whereas no gold particles could
be observed on the viral nucleocapsids when using the same
antibody (Fig. 4b). The control experiments showed that no
gold particles were found on the envelopes of WSSV virions
(Fig. 4c) when using pre-immune mouse serum as the
primary antibody. All of these studies demonstrated that
VP24 is an envelope protein of WSSV.
Fig. 1. Transmembrane analysis of VP24 amino acids trans-
lated from the DNA sequence. The potential transmembrane











































Fig. 2. Purified WSSV virions are subjected to treatment with
1 % NP-40. The left panel shows the gel samples, whilst the
right panel shows a Western blot of an equivalent gel probed
with anti-VP24 serum. The major structural proteins, VP28,





































Fig. 3. Purified WSSV virions are subjected to treatment with
1 % Triton X-114. The left panel shows the gel samples, whilst
the right panel shows a Western blot of an equivalent gel
probed with anti-VP24 serum. VP24 is indicated by an arrow.
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Association of VP24 and VP28
In order to characterize the functional properties of VP24, a
far-Western experiment using biotinylated rVP24 was
performed. The viral structural proteins were separated by
SDS-PAGE and transferred to a membrane, renatured and
subsequently incubated with biotinylated rVP24 or bio-
tinylated GST as a negative control. After detection using
AP-conjugated streptavidin, we observed a prominent band
corresponding to VP28, suggesting that there is an
interaction between VP24 and VP28 (Fig. 5a). No signal
was detected in the GST control.
To further confirm the VP24–VP28 interaction, coimmuno-
precipitation analysis was performed. As shown in Fig. 5(b),
VP28 was immunoprecipitated with the anti-VP24 anti-
body. The results of the Western analysis (Figs 2 and 3)
showed that there was no cross-reactivity of anti-VP24 anti-
body with VP28, so VP28 was pulled down by interacting
with VP24.
VP24 antibody neutralization in vivo
The anti-VP24 IgG was used in an in vivo neutralization
assay. A constant amount of WSSV was incubated with
various amounts of anti-VP24 IgG and injected into
crayfish. The results (Fig. 6) showed that the positive-
control group (WSSV only, group 1) displayed 100 % mor-
tality by day 7 post-infection, whereas the negative-control
group (0?9 % NaCl, group 6) showed no mortality. Addition
of anti-GST IgG (group 2) resulted in a small initial delay of
mortality, which reached 100 % by day 9. This could be due
to compounds injected in crayfish stimulating the host-
defence system. The groups injected with various amounts
of anti-VP24 IgG mixed with virions exhibited 100 %
mortality by days 12, 15 and 19 for groups 3–5, respectively.
The above experiments were performed once again and the
same result could be obtained. Therefore, it could be
concluded that the infection of WSSV was truly delayed or
neutralized by the antibody against VP24.
DISCUSSION
WSSV contains five major structural proteins, VP28, VP26,
VP24, VP19 and VP15. In previous studies, VP28, VP26 and
VP19 were shown to be associated with the viral envelope
(van Hulten et al., 2001b, 2002; Zhang et al., 2002a, b; Xie &
Yang, 2005) and VP15 with the nucleocapsid (van Hulten
(a) (b) (c)
Fig. 4. Immunoelectron microscopy of intact virions and nucleocapsids with anti-VP24 serum followed by gold particle-
conjugated secondary antibody. (a) Immunoelectron microscopy of purified WSSV virions using anti-VP24 serum. Gold
particles are indicated by arrows. (b) Immunoelectron microscopy of WSSV nucleocapsids using anti-VP24 serum as the


































Fig. 5. (a) Far-Western analysis using biotinylated rVP24. The
left panel shows the gel samples of viral structural proteins,
whilst the middle and right panels show a far-Western analysis
of an equivalent gel with biotinylated rVP24 (Bio–VP24) and
biotinylated GST (Bio–GST), respectively. VP28 is indicated by
an arrow. (b) VP28 is immunoprecipitated with anti-VP24 anti-
body. VP28 and VP24 are indicated by arrows.
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et al., 2002; Witteveldt et al., 2005). VP24 was initially
thought to be a nucleocapsid protein (van Hulten et al.,
2000b), but its localization was not confirmed by immuno-
electron microscopy. Recent data in the literature showed
that VP24 was present exclusively in the envelope fraction
when high-purity virions were subjected to non-ionic-
detergent treatment (Li et al., 2005; Xie & Yang, 2005; Xie
et al., 2005), indicating that it might be an envelope pro-
tein. Furthermore, examination of the predicted protein
sequence also suggested that VP24 is sufficiently hydro-
phobic to be envelope-associated (van Hulten et al., 2000a).
Therefore, we decided to undertake a detailed biochemical
characterization of VP24.
Using our highly purified virus, we used a method described
by van Hulten et al. (2000b) to separate viral envelopes from
the nucleocapsids and obtained cleaner extraction, such that
VP24 and the major envelope proteins, e.g. VP28 and VP19,
were found exclusively in the envelope fraction (Fig. 2).
However, we could not exclude the possibility that different
methods and protocols used for separating the envelope
or nucleocapsid protein might produce different results.
Therefore, we used another detergent (Triton X-100) to
extract envelope proteins, obtaining the same results. In
addition, Triton X-114 extraction and immunoelectron
microscopy confirmed that VP24 behaves as an envelope
protein (Figs 3 and 4). According to our current data, this
would mean that VP24 is probably envelope-associated.
To date, the function of VP24 in the life cycle of the virus
is still unknown. Amino acid analysis of VP24 and VP28
indicated that these two proteins have about 43 % amino
acid identity (van Hulten et al., 2000a) and it was reported
that VP28 could bind to shrimp cells as an attachment
protein and help the virus to enter the cytoplasm (Yi et al.,
2004). Therefore, we were originally interested in examining
whether VP24 is involved in the process of virus entry, as is
VP28. First, a cell-binding assay in vitro using biotinylated
rVP24 was performed. The result indicated that VP24 could
not bind to host-cell membranes (data not shown). Sub-
sequently, in order to study further whether VP24 is involved
in WSSV infection, an in vivo neutralization experiment
with anti-VP24 IgG was conducted. The results revealed that
infection by WSSV could be delayed significantly by anti-
VP24 IgG, suggesting that VP24 plays a role in the WSSV
infection. In addition, we have provided evidence for the
direct interaction of VP24 and VP28 and we further
postulate that VP24 and VP28 form a protein complex and
participate in virus infection together.
Besides participation in virus infection, envelope proteins
often play vital roles in virus assembly and budding (Chazal
& Gerlier, 2003). Although during the last decade, intensive
efforts have been undertaken for characterization of the
structural genes, the initial steps in WSSV morphogenesis
are poorly understood. Crucial to the understanding of the
molecular events is the need to identify the many molecules
involved. In this study, additional in vitro experiments pro-
vided evidence for the direct interaction of VP24 and VP28,
the first time that the interaction between these structural
proteins has been identified in WSSV. It was reported that
protein–protein interactions are needed for viral morpho-
genesis of Vaccinia virus (VACV) (Szajner et al., 2003).
VACV G7L protein interacts with the A30L protein and the
stability of each was dependent on its association with the
other. Both structural proteins are required for the associa-
tion of dense viroplasm with viral membranes. Although, at
present, we could not conclude whether VP24 and VP28 are
required for WSSV morphogenesis, the identification of the
VP24–VP28 interaction might provide insight to further
investigations of the mode of morphogenesis.
Further research is required to reveal the exact role of VP24
in WSSV infection or morphogenesis. Efforts to identify
additional proteins associated with VP24 are in progress.
We anticipate that further exploration of the functions of
envelope proteins, including VP24, will facilitate a better
understanding of the molecular mechanism underlying
WSSV infection and assembly and may be helpful for the
diagnosis and control of virus infection.
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